Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, announced today that Fredric Tomczyk, Chief Executive Officer, Jill Griebenow, Executive Vice President and Chief Financial Officer, David Howson, Executive Vice President and Global President, and Chris Isaacson, Executive Vice President and Chief Operating Officer, will present at the BofA Securities […]

Heger Makes History Securing the Ultimate Off-Road Racing Triple Crown with Wins at the 2024 Baja 1000, 2025 Dakar Rally, and Both King of the Hammers Desert Challenge and UTV Hammers Championship Yesterday in the Johnson Valley desert,RZR Factory Racing's Brock Heger didn't just win the King of the Hammers (KOH) UTV Hammers Championship-he dominated.

(Other OTC:PRKA),(OTC US:PRKA), Management to host conference call on Monday, February 10, 2025, at 4:30 PM ET PINE MOUNTAIN, Georgia, Feb. 07, 2025 (GLOBE NEWSWIRE) — Parks! America, Inc. (OTCPink: PRKA), today announced its financial results for the first quarter of fiscal year 2025 ended December 29, 2024. The summary information in this press release

(TSX-V:WRI),(Boerse Frankfurt – Freiverkehr:WSE), TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) — Waseco Resources Inc. (the “Company”) (TSX-V:WRI) reports that Marigold Mining Company (“Marigold”) has exercised its rights of termination under the Battle Mountain Ridge Option Agreement, dated July 1, 2020, between Marigold and Waseco Resources US Inc., a wholly owned subsidiary of Waseco Resources Inc.

(NASDAQ:TPST), BRISBANE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 45,000 shares of its common

(NasdaqGM:STIM), MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 15,750

(NYSE MKT:CLM),(NYSE MKT:CRF), NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) — Cornerstone Strategic Investment Fund, Inc. (NYSE American: CLM) (CUSIP: 21924B302) and Cornerstone Total Return Fund, Inc. (NYSE American: CRF) (CUSIP: 21924U300), (individually the “Fund” or, collectively, the “Funds”), each a closed-end management investment company, announced that in keeping with each Fund's previously adopted monthly

(NasdaqGM:FULC), CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of

(NASDAQ:ORIC), SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on February 3, 2025 (the “Grant Date”), ORIC granted a total of 29,600 non-qualified stock options and 4,800 restricted

(NYSE MKT:FRD), LONGVIEW, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) — Friedman Industries, Incorporated (NYSE American: FRD) announced today its results of operations for the third fiscal quarter ended December 31, 2024. December 31, 2024 Quarter Highlights: Sales of approximately $94.1 million Working capital balance at quarter-end of approximately $107 million Operating cash flow of approximately